Medicines Australia working to minimize supply shortages

22 July 2022
australia_big-1

Medicines Australia and the Generic and Biosimilars Medicines Association (GBMA) have shared concerns about medicine shortages that are impacting patients in the country.

The Therapeutic Goods Administration (TGA) has listed 47 medicines that are experiencing critical shortages due to issues brought about by the COVID-19 pandemic, with many having limited availability. Attempting to deal with ongoing shortages has formed a significant part of recent strategic agreements between Medicines Australia and the government.

Elizabeth de Somer, chief executive of Medicines Australia, said: “The pandemic has highlighted the complexities and vulnerabilities in global medicine supply chains and has increased the focus on medicine shortages in Australia.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Today's issue

Company Spotlight





More Features in Generics